Close

Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success

Go back to Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 201.21 -0.78 (0.39%)
Previous Close $201.99    52 Week High $333.65 
Open $201.21    52 Week Low $223.02 
Day High $201.21    P/E 25.76 
Day Low $201.21    EPS $7.81 
Volume 16,291